Session date: 
Wednesday, April 8, 2020 - 7:45am to 8:45am
Location: 
Froedtert Hospital - Cancer Center
9200 W. Wisconsin Avenue
Room L
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 
This educational activity is designed to provide a learning environment that provides interactive discussions on up to date medical information, treatment plans, options and protocols, along with the risks, benefits and outcomes of treatment on adult musculoskeletal oncology patients. This is a discussed in a multidisciplinary format that creates a well rounded unbiased discussion amongst colleagues.  It creates an environment for dynamic discussion and debates on patient care and the treatment resources available. It provides the opportunity for consistent tailored individual treatment protocols per patient.

 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
Physician
Physician (fellow/resident)
Physician Assistant
Nurse
Nurse Practitioner
AP/NP
Allied Health Care Professionals
Learning objectives: 
  • Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
  • Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
  • Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
  • Publish research that is up to date and relevant to current literature
Faculty & credentials: 

All persons in control of content have NO relevant financial relationships to disclose except: 

 
Name:Company:Role:

Don Hackbarth, MD

Pete Rossi, MD

 

Sean Tutton, MD

 

Brandon Rebholz, MD

John Neilson, MD

MTF Biologics

Silk Road Medical

Termo Aortic

Stryker

BTG/BSC

Zimmer/Biomet

MTF

Board of Directors

Speaker

Consultant

Consultant

Consultant

Consultant

Board Member

 
In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Contact

Name: 
Lori Hollingsworth-Burds PA-C
Phone number: 
+1 (414) 955-3226